Lisa M. Forman, MD, MSCE
Assistant Professor of Medicine
Director, Gastroenterology Fellowship Program
Director, Gastroenterology Fellowship Program
Education
- Medical School:
- 1991 - 1995 MD University of Pennsylvania
- 1999 - 2001 MSCE University of Pennsylvania (Epidemiology)
- Residency: 6/95 - 7/98 Medicine, University of Pennsylvania
- Fellowship:
- 7/98-7/01 Gastroenterology, University of Pennsylvania
- 9/99-5/01 Clinical Epidemiology, University of Pennsylvania
- Board Certified in Internal Medicine and Gastroenterology
Honors and Awards
- Phi Beta Kappa, Tufts University
- Anna Quincy Churchill Prize in General Biology, Tufts University
- Summa Cum Laude, Tufts University
- Alpha Omega Alpha, University of Pennsylvania
- Penn Pearls Teaching Award, University of Pennsylvania
- Clinical Research Curriculum Award, University of Pennsylvania
- Edward Raffensperger Award for Excellence in Teaching, University of Pennsylvania
- Clinical Research Curriculum Award, University of Pennsylvania
- Stanley Bradley Research Award, University of Pennsylvania
Faculty Appointments
- 7/01 - Instructor of Medicine, Division of Gastroenterology, University of Pennsylvania
- 5/02 - Assistant Professor of Medicine, Division of Gastroenterology-Hepatology, University of Colorado Health Sciences
Research Interests
Dr. Forman's research interests include NASH, HCV, hepatic encephalopathy, liver transplantation, and metabolic complications after liver transplantation.
Representative Publications
- Forman LM, Simmons DA, Diamond RH. Hepatic failure in a patient taking rosiglitazone. Ann Int Med 2000;2:118-21.
- Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-96.
- Forman LM. To transplant or not to transplant recurrent hepatitis C and liver failure. Clinics in Liver Disease 2003;7:615-29.
- Everson GT, Trotter JF, Kugelmas M, Forman LM. Immunosuppression in liver transplantation. Minerva Chirurgica 2003; 58:725-740.
- Medeiros PC, Seligman PA, Everson GT, Forman LM. Possible autoimmune thrombocytopenia associated with pegylated interferon-α2a plus ribavirin treatment for hepatitis C. J Clin Gastroenterol 2003;38:84-86.(download PDF)
- Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection. Liver Transpl 2003;9:1159-1165. (download PDF)
- Abt PL, Desai NM, Crawford MD, Forman LM, Markmann JW, Olthoff KM, Markmann JF. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2003;239:87-92. (download PDF)
- Dart R, Forman LM. Acute Liver Failure. In Dart RC (ed): Medical Toxicology, 3rd Edition Philadelphia; Lippincott, Williams & Wilkin, 2004: 77-78.
- Forman LM, Lucey MR. Setting limits on selection of adults for liver transplantation. Transplantation 2004; 77:19-21.
- Piasecki B, Forman LM, Chang KM. Acute and Clinical Viral Hepatitis. In Rustgi AR (ed): Requisites in Gastroenterology Vol 3, Philadelphia; Mosby, Inc. 2004: 51-84.
- Forman LM, Trotter JF, Edmond J. Living donor transplantation and hepatitis C [editorial]. Liver Transpl 2004;10:347-348.
- Hayashi PH, Trotter JF, Forman L, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD. Liv Transpl 2004;10:42-48. (download PDF)
- Hayashi PH, Ludkowski M, Forman LM, et al. Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation. Am J Transpl 2004; 4:782-787. (download PDF)
- Hayashi PH, Mao J, Slater K, Forman LM. Atrial septal perforation from TIPS stent migration. J Vasc Interv Radiol 2004;15:629-32. (download PDF)
- Forman LM. Long-term outcomes post-transplantation. In Everson GT, Trotter JF (eds): Liver Transplantation: Challenging Controversies and Topics, Humana Press, 2007.
